Ve
Non vérifié

Veraxa Biotech AG

Ce que nous écrivons

Annonces ÉconomiquesBiotechnologieManagement/Organisation d'EntreprisePublicité/Marketing/Médias/Communication
04/09/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
1.00
24/08/2026
Biotechnologie
Annonces Économiques
Management/Organisation d'Entreprise
VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance
1.00
27/07/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
1.00
24/07/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
1.00
23/07/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio
1.00
20/07/2026
Biotechnologie
Annonces Économiques
Publicité/Marketing/Médias/Communication
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
1.00
13/07/2026
Biotechnologie
Publicité/Marketing/Médias/Communication
Annonces Économiques
VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0